share_log

Oppenheimer Maintains Outperform on Achieve Life Sciences, Lowers Price Target to $18

Oppenheimer Maintains Outperform on Achieve Life Sciences, Lowers Price Target to $18

奥本海默在Achieve Life Sciences上保持跑赢大盘,将目标股价下调至18美元
Benzinga ·  2023/12/12 06:30

Oppenheimer analyst Francois Brisebois maintains Achieve Life Sciences (NASDAQ:ACHV) with a Outperform and lowers the price target from $21 to $18.

奥本海默分析师弗朗索瓦·布里塞波依斯维持Achieve Life Sciences(纳斯达克股票代码:ACHV)的涨幅为跑赢大盘,并将目标股价从21美元下调至18美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发